A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer

Cancer immunotherapies have generated remarkable clinical responses for some patients with advanced/metastatic disease, prompting exploration of rational combination therapies to bolster anti-tumor immunity in patients with limited response or those who experience tumor progression following an init...

Descripción completa

Detalles Bibliográficos
Autores principales: McGray, A. J. R., Eppolito, C., Miliotto, A., Singel, K. L., Stephenson, K., Lugade, A., Segal, B. H., Keler, T., Webster, G., Lichty, B., Kozbor, D., Odunsi, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057655/
https://www.ncbi.nlm.nih.gov/pubmed/33880648
http://dx.doi.org/10.1007/s00262-021-02936-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057655/
https://www.ncbi.nlm.nih.gov/pubmed/33880648
http://dx.doi.org/10.1007/s00262-021-02936-1

Ejemplares similares